USAMRIID | Global Biodefense

Menu

USAMRIID Study Leads to Approval of New Smallpox Vaccine

by Global Biodefense October 20, 2019, 17:01
Cutting Edge Chemical and Biological Defense Science: Hot Topics at CBD S&T 2019

by Saskia Popescu, PhD October 16, 2019, 08:59
DoD Inspector General to Reevaluate Select Agent Facilities, Biosafety Oversight

by Stephanie Lizotte September 9, 2019, 15:23
Research Halted at USAMRIID Over Biosafety Issues

by Stephanie Lizotte August 5, 2019, 07:00
USAMRIID Seeks Isolation and Purification of Ovatoxins

by Global Biodefense June 15, 2019, 11:12
Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons

by Global Biodefense April 15, 2019, 08:16
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

by Global Biodefense October 4, 2018, 03:30
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994

by Global Biodefense July 16, 2018, 05:28
USAMRIID Temporarily Halts Activity at BSL-3 and BSL-4 Laboratories

by Stephanie Lizotte June 2, 2018, 09:07
USAMRIID Awards Select Agent Research Reagents Contract

by Stephanie Lizotte May 16, 2018, 01:44
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
MIT, USAMRIID Develop Algorithm for Early Warning of Exposure to Pathogens

by Global Biodefense February 27, 2018, 13:39
Monkeypox in Nigeria: The Value of Local Surveillance and Genetic Sequencing

by Global Biodefense February 19, 2018, 01:15
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study

by Global Biodefense February 19, 2018, 01:10
Enhancing the Efficacy of Adenovirus-5 Vectored Ebola Virus Vaccines

by Global Biodefense May 25, 2017, 09:36

Congratulations. You've reached the end of the internet.

Back to Top

close